EMPLOYMENT AGREEMENTEmployment Agreement • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WHEREAS Cynapsus is developing a sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease;
SUPPLEMENTAL INDENTUREWarrant Indenture • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
NOW THEREFORE in consideration of the mutual promises contained in this Supplemental Indenture and other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the parties agree as follows:
THIS LEASE made the 1st day of MAY , 2008. IN PURSUANCE OF THE SHORT FORMS OF LEASES ACT. BETWEEN:Lease Agreement • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
WITNESSETH that in consideration of the rents hereby reserved and the covenants herein contained on the part of the Tenant, the Landlord hereby leases to the Tenant a portion of the land and building municipally known as 828 Richmond Street West, in the City of Toronto, Province of Ontario (the “Premises”) established at 3200 square feet of useable area together with use of the common area, being the ground level, as outlined in red on the floor plan attached as Schedule “A”.
THIS LEASE EXTENTION AGREEMENT made effective as of the 1st day of May 2014 B E T W E E N:Lease Extension Agreement • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations
SUPPLEMENTAL INDENTURESupplemental Indenture • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
NOW THEREFORE in consideration of the mutual promises contained in this Supplemental Indenture and other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the parties agree as follows:
Director and Officer Indemnification AgreementIndemnification Agreement • August 14th, 2015 • Cynapsus Therapeutics Inc. • Pharmaceutical preparations • Ontario
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made as of this 6th day of May, 2013, between Cynapsus Therapeutics Inc. (the “Corporation”), a corporation amalgamated under the Canada Business Corporations Act and _________________________________ (the “Indemnified Party”).
